

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.18299207 |
| 2 | formation of translation preinitiation complex (GO:0001731) | 4.94815414 |
| 3 | maturation of SSU-rRNA (GO:0030490) | 4.54483729 |
| 4 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.52642892 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.42345115 |
| 6 | purine nucleobase biosynthetic process (GO:0009113) | 4.40220119 |
| 7 | ribosome assembly (GO:0042255) | 4.39225474 |
| 8 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.32889942 |
| 9 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.32352224 |
| 10 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.27665457 |
| 11 | DNA deamination (GO:0045006) | 4.24179720 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 4.18095630 |
| 13 | * negative regulation of ligase activity (GO:0051352) | 4.16873072 |
| 14 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.16873072 |
| 15 | establishment of integrated proviral latency (GO:0075713) | 4.09294147 |
| 16 | ribosomal large subunit biogenesis (GO:0042273) | 4.07481717 |
| 17 | respiratory electron transport chain (GO:0022904) | 4.07200389 |
| 18 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.05311517 |
| 19 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.02336319 |
| 20 | electron transport chain (GO:0022900) | 3.97288406 |
| 21 | ribosomal small subunit biogenesis (GO:0042274) | 3.95583382 |
| 22 | ribosome biogenesis (GO:0042254) | 3.93165477 |
| 23 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.91258103 |
| 24 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.89953704 |
| 25 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.88910437 |
| 26 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.86290891 |
| 27 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.85105493 |
| 28 | viral transcription (GO:0019083) | 3.82969059 |
| 29 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.81780733 |
| 30 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.81780733 |
| 31 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.81549874 |
| 32 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.81549874 |
| 33 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.80511283 |
| 34 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.80511283 |
| 35 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.80511283 |
| 36 | translational termination (GO:0006415) | 3.79019312 |
| 37 | DNA replication initiation (GO:0006270) | 3.78738279 |
| 38 | DNA strand elongation (GO:0022616) | 3.77893329 |
| 39 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.77036785 |
| 40 | translational initiation (GO:0006413) | 3.76805711 |
| 41 | folic acid metabolic process (GO:0046655) | 3.74750860 |
| 42 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.74585830 |
| 43 | cullin deneddylation (GO:0010388) | 3.70899662 |
| 44 | mitotic metaphase plate congression (GO:0007080) | 3.70700595 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.70111893 |
| 46 | * positive regulation of ligase activity (GO:0051351) | 3.65069859 |
| 47 | establishment of viral latency (GO:0019043) | 3.63856361 |
| 48 | protein targeting to mitochondrion (GO:0006626) | 3.63088514 |
| 49 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.62927509 |
| 50 | protein deneddylation (GO:0000338) | 3.60360918 |
| 51 | translational elongation (GO:0006414) | 3.59735764 |
| 52 | ribosomal small subunit assembly (GO:0000028) | 3.57403743 |
| 53 | spliceosomal snRNP assembly (GO:0000387) | 3.57095542 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.55541922 |
| 55 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.54685347 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54606765 |
| 57 | rRNA processing (GO:0006364) | 3.53464052 |
| 58 | protein maturation by protein folding (GO:0022417) | 3.48800055 |
| 59 | * regulation of cellular amine metabolic process (GO:0033238) | 3.48002949 |
| 60 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.47322157 |
| 61 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.47299899 |
| 62 | rRNA modification (GO:0000154) | 3.46572918 |
| 63 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.46260152 |
| 64 | histone arginine methylation (GO:0034969) | 3.43886356 |
| 65 | 7-methylguanosine mRNA capping (GO:0006370) | 3.43318049 |
| 66 | DNA replication checkpoint (GO:0000076) | 3.42421311 |
| 67 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.40171648 |
| 68 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.40171648 |
| 69 | rRNA metabolic process (GO:0016072) | 3.39767941 |
| 70 | establishment of protein localization to mitochondrion (GO:0072655) | 3.39631618 |
| 71 | L-methionine salvage (GO:0071267) | 3.39184112 |
| 72 | L-methionine biosynthetic process (GO:0071265) | 3.39184112 |
| 73 | amino acid salvage (GO:0043102) | 3.39184112 |
| 74 | translation (GO:0006412) | 3.36880994 |
| 75 | DNA unwinding involved in DNA replication (GO:0006268) | 3.35943582 |
| 76 | * regulation of ligase activity (GO:0051340) | 3.32117580 |
| 77 | RNA capping (GO:0036260) | 3.31692151 |
| 78 | 7-methylguanosine RNA capping (GO:0009452) | 3.31692151 |
| 79 | protein localization to mitochondrion (GO:0070585) | 3.30541291 |
| 80 | regulation of mitochondrial translation (GO:0070129) | 3.29504473 |
| 81 | protein localization to kinetochore (GO:0034501) | 3.28192724 |
| 82 | telomere maintenance via recombination (GO:0000722) | 3.27447813 |
| 83 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.25714721 |
| 84 | * cell cycle G1/S phase transition (GO:0044843) | 3.25714721 |
| 85 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.23735740 |
| 86 | termination of RNA polymerase III transcription (GO:0006386) | 3.22512735 |
| 87 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.22512735 |
| 88 | * negative regulation of protein ubiquitination (GO:0031397) | 3.22456364 |
| 89 | cellular component biogenesis (GO:0044085) | 3.20999213 |
| 90 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.20550591 |
| 91 | inner mitochondrial membrane organization (GO:0007007) | 3.20013440 |
| 92 | IMP biosynthetic process (GO:0006188) | 3.19058128 |
| 93 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.18610591 |
| 94 | * positive regulation of cell cycle arrest (GO:0071158) | 3.18528357 |
| 95 | viral mRNA export from host cell nucleus (GO:0046784) | 3.16255700 |
| 96 | pseudouridine synthesis (GO:0001522) | 3.14754627 |
| 97 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.14092254 |
| 98 | cotranslational protein targeting to membrane (GO:0006613) | 3.13487423 |
| 99 | regulation of spindle organization (GO:0090224) | 3.12207536 |
| 100 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.12003621 |
| 101 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.11453859 |
| 102 | protein targeting to ER (GO:0045047) | 3.11064894 |
| 103 | cellular protein complex disassembly (GO:0043624) | 3.10179684 |
| 104 | peptidyl-arginine methylation (GO:0018216) | 3.09983400 |
| 105 | peptidyl-arginine N-methylation (GO:0035246) | 3.09983400 |
| 106 | mitotic recombination (GO:0006312) | 3.09892768 |
| 107 | ATP synthesis coupled proton transport (GO:0015986) | 3.09867719 |
| 108 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09867719 |
| 109 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.09578674 |
| 110 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.09578674 |
| 111 | * signal transduction in response to DNA damage (GO:0042770) | 3.09160583 |
| 112 | viral life cycle (GO:0019058) | 3.07218775 |
| 113 | mitotic nuclear envelope disassembly (GO:0007077) | 3.06873060 |
| 114 | chaperone-mediated protein complex assembly (GO:0051131) | 3.04373224 |
| 115 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.02649518 |
| 116 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.02151731 |
| 117 | protein complex biogenesis (GO:0070271) | 3.01429195 |
| 118 | metaphase plate congression (GO:0051310) | 3.00514183 |
| 119 | telomere maintenance via telomere lengthening (GO:0010833) | 2.99717040 |
| 120 | IMP metabolic process (GO:0046040) | 2.98323330 |
| 121 | protein localization to endoplasmic reticulum (GO:0070972) | 2.98038247 |
| 122 | oxidative phosphorylation (GO:0006119) | 2.96177101 |
| 123 | CENP-A containing nucleosome assembly (GO:0034080) | 2.95811584 |
| 124 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.95463819 |
| 125 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.94602729 |
| 126 | de novo posttranslational protein folding (GO:0051084) | 2.94593633 |
| 127 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.94345362 |
| 128 | maturation of 5.8S rRNA (GO:0000460) | 2.93390154 |
| 129 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.92743803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.36376895 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.18239781 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.01869971 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.58989865 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.39726527 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.39256762 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.35900435 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.35691351 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.21142098 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.98625890 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.96789979 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89371930 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.89029166 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.80610391 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.73823446 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.65442425 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.58053866 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.48231095 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.46558569 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.43274714 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.39543094 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.28355607 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22638673 |
| 24 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.17518371 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.14219645 |
| 26 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03221847 |
| 27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.00937477 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.97542142 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94105490 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90496828 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.90200253 |
| 32 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.89982182 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.89326356 |
| 34 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88739976 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.87406192 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86007551 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.78853437 |
| 38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.72370830 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68722480 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.67452201 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66429296 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61313978 |
| 43 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.58005563 |
| 44 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57921068 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56624814 |
| 46 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52693911 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51915219 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.49009717 |
| 49 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.43813263 |
| 50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41085111 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40186615 |
| 52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40168879 |
| 53 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.37390382 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36732198 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35504792 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32772711 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32283500 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29940372 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29794867 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28528753 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26990946 |
| 62 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24933489 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24233244 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24216579 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21309345 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19902719 |
| 67 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18608234 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17058214 |
| 69 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16639892 |
| 70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15379923 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15256863 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14889778 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.11397528 |
| 74 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11325753 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08999024 |
| 76 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08885785 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07461322 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06850569 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06405359 |
| 80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05189510 |
| 81 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.03996605 |
| 82 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.03788466 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02617862 |
| 84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.01204760 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01195225 |
| 86 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00327499 |
| 87 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99567029 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99049745 |
| 89 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98923559 |
| 90 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98166227 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97203881 |
| 92 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96974385 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96972999 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96833356 |
| 95 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96790553 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96302287 |
| 97 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95235743 |
| 98 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95200713 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94251243 |
| 100 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91688914 |
| 101 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91688615 |
| 102 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91014947 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89141262 |
| 104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.88953493 |
| 105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88525680 |
| 106 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88108046 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86198931 |
| 108 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.83852818 |
| 109 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83245744 |
| 110 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.81470284 |
| 111 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.81443198 |
| 112 | MYC_22102868_ChIP-Seq_BL_Human | 0.80566155 |
| 113 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.79077042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.96561641 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.73361506 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.37137739 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.01304574 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.95248219 |
| 6 | MP0003077_abnormal_cell_cycle | 3.83962756 |
| 7 | MP0003718_maternal_effect | 3.00850716 |
| 8 | MP0008058_abnormal_DNA_repair | 2.93887799 |
| 9 | * MP0008932_abnormal_embryonic_tissue | 2.87702538 |
| 10 | MP0001730_embryonic_growth_arrest | 2.55595015 |
| 11 | MP0008057_abnormal_DNA_replication | 2.29389403 |
| 12 | MP0009840_abnormal_foam_cell | 2.24235466 |
| 13 | MP0003786_premature_aging | 2.24021940 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.17567765 |
| 15 | MP0003123_paternal_imprinting | 2.08548869 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.08537306 |
| 17 | MP0009697_abnormal_copulation | 2.08174934 |
| 18 | MP0003186_abnormal_redox_activity | 2.00774633 |
| 19 | MP0008260_abnormal_autophagy | 1.94449802 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.93065035 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.89406546 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.87374380 |
| 23 | MP0006035_abnormal_mitochondrial_morpho | 1.85805601 |
| 24 | MP0000358_abnormal_cell_content/ | 1.73823563 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.72191026 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.71855645 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.63742302 |
| 28 | MP0001697_abnormal_embryo_size | 1.62185972 |
| 29 | MP0005408_hypopigmentation | 1.61645720 |
| 30 | * MP0002080_prenatal_lethality | 1.59620673 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.56700322 |
| 32 | * MP0001672_abnormal_embryogenesis/_devel | 1.55659491 |
| 33 | * MP0005380_embryogenesis_phenotype | 1.55659491 |
| 34 | MP0008789_abnormal_olfactory_epithelium | 1.46205152 |
| 35 | MP0003315_abnormal_perineum_morphology | 1.45710240 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.45687745 |
| 37 | MP0001727_abnormal_embryo_implantation | 1.45505952 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.42905414 |
| 39 | * MP0003984_embryonic_growth_retardation | 1.37977036 |
| 40 | * MP0002088_abnormal_embryonic_growth/wei | 1.36182684 |
| 41 | MP0002269_muscular_atrophy | 1.35286074 |
| 42 | MP0000313_abnormal_cell_death | 1.32072578 |
| 43 | MP0010307_abnormal_tumor_latency | 1.30904680 |
| 44 | MP0002085_abnormal_embryonic_tissue | 1.30151438 |
| 45 | MP0005451_abnormal_body_composition | 1.23312077 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.23035781 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.22073300 |
| 48 | MP0001346_abnormal_lacrimal_gland | 1.20990875 |
| 49 | MP0003136_yellow_coat_color | 1.16116868 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.15369696 |
| 51 | MP0008995_early_reproductive_senescence | 1.14421372 |
| 52 | MP0002160_abnormal_reproductive_system | 1.14227722 |
| 53 | MP0004084_abnormal_cardiac_muscle | 1.12655410 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.09595445 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.08799605 |
| 56 | MP0003646_muscle_fatigue | 1.07710488 |
| 57 | MP0005395_other_phenotype | 1.07508986 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.07083009 |
| 59 | MP0002132_abnormal_respiratory_system | 1.07060915 |
| 60 | MP0002086_abnormal_extraembryonic_tissu | 1.06988951 |
| 61 | MP0001881_abnormal_mammary_gland | 1.05175075 |
| 62 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04515734 |
| 63 | * MP0002084_abnormal_developmental_patter | 1.03886368 |
| 64 | MP0002210_abnormal_sex_determination | 1.03112929 |
| 65 | MP0000747_muscle_weakness | 1.01183954 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.99843071 |
| 67 | MP0000490_abnormal_crypts_of | 0.99656138 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 0.98217924 |
| 69 | MP0005330_cardiomyopathy | 0.96279139 |
| 70 | MP0005266_abnormal_metabolism | 0.96000438 |
| 71 | MP0001145_abnormal_male_reproductive | 0.95215551 |
| 72 | MP0005394_taste/olfaction_phenotype | 0.94440105 |
| 73 | MP0005499_abnormal_olfactory_system | 0.94440105 |
| 74 | MP0005023_abnormal_wound_healing | 0.93855410 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93334989 |
| 76 | MP0001529_abnormal_vocalization | 0.90603881 |
| 77 | MP0005384_cellular_phenotype | 0.90180043 |
| 78 | MP0000749_muscle_degeneration | 0.88128471 |
| 79 | MP0005389_reproductive_system_phenotype | 0.87492329 |
| 80 | MP0001929_abnormal_gametogenesis | 0.86695751 |
| 81 | MP0003941_abnormal_skin_development | 0.86589259 |
| 82 | MP0000343_altered_response_to | 0.85463216 |
| 83 | MP0009053_abnormal_anal_canal | 0.85343898 |
| 84 | MP0001764_abnormal_homeostasis | 0.85301285 |
| 85 | MP0005501_abnormal_skin_physiology | 0.84998449 |
| 86 | MP0005332_abnormal_amino_acid | 0.82434571 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.81956364 |
| 88 | MP0002090_abnormal_vision | 0.81467455 |
| 89 | MP0002938_white_spotting | 0.81018016 |
| 90 | MP0001905_abnormal_dopamine_level | 0.79986167 |
| 91 | MP0008873_increased_physiological_sensi | 0.79375764 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.78634959 |
| 93 | MP0000653_abnormal_sex_gland | 0.77892216 |
| 94 | MP0001661_extended_life_span | 0.77800039 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.77703326 |
| 96 | MP0001542_abnormal_bone_strength | 0.76984731 |
| 97 | MP0003119_abnormal_digestive_system | 0.76366132 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.74706236 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.74519995 |
| 100 | MP0005621_abnormal_cell_physiology | 0.74342923 |
| 101 | MP0004133_heterotaxia | 0.73520917 |
| 102 | MP0001853_heart_inflammation | 0.72862766 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.72077282 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 0.68387672 |
| 105 | MP0003878_abnormal_ear_physiology | 0.68387672 |
| 106 | MP0001186_pigmentation_phenotype | 0.67592981 |
| 107 | MP0002697_abnormal_eye_size | 0.66421071 |
| 108 | MP0001243_abnormal_dermal_layer | 0.66071401 |
| 109 | MP0009672_abnormal_birth_weight | 0.65541627 |
| 110 | MP0001293_anophthalmia | 0.65475132 |
| 111 | MP0005171_absent_coat_pigmentation | 0.64450260 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.62676330 |
| 113 | MP0000598_abnormal_liver_morphology | 0.62610709 |
| 114 | MP0002822_catalepsy | 0.62419042 |
| 115 | MP0002111_abnormal_tail_morphology | 0.60382520 |
| 116 | MP0002722_abnormal_immune_system | 0.60244462 |
| 117 | MP0000858_altered_metastatic_potential | 0.59886797 |
| 118 | MP0003938_abnormal_ear_development | 0.59618965 |
| 119 | MP0002796_impaired_skin_barrier | 0.59487838 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.59034233 |
| 121 | MP0004233_abnormal_muscle_weight | 0.57645994 |
| 122 | MP0000049_abnormal_middle_ear | 0.57537629 |
| 123 | MP0000627_abnormal_mammary_gland | 0.57514231 |
| 124 | MP0000751_myopathy | 0.57145648 |
| 125 | MP0000689_abnormal_spleen_morphology | 0.56000894 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.55882136 |
| 127 | MP0005083_abnormal_biliary_tract | 0.55606594 |
| 128 | MP0004147_increased_porphyrin_level | 0.54532662 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.54040814 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.54040814 |
| 131 | MP0009379_abnormal_foot_pigmentation | 0.53989937 |
| 132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53861594 |
| 133 | MP0002751_abnormal_autonomic_nervous | 0.52857783 |
| 134 | MP0002736_abnormal_nociception_after | 0.52645719 |
| 135 | MP0001849_ear_inflammation | 0.50777293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.29522850 |
| 2 | Cerebral hypomyelination (HP:0006808) | 4.29426971 |
| 3 | Breast hypoplasia (HP:0003187) | 4.14781432 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.04463754 |
| 5 | Microvesicular hepatic steatosis (HP:0001414) | 3.93150257 |
| 6 | Carpal bone hypoplasia (HP:0001498) | 3.73188462 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 3.73056705 |
| 8 | Abnormality of glycolysis (HP:0004366) | 3.68260404 |
| 9 | Increased serum pyruvate (HP:0003542) | 3.68260404 |
| 10 | Oral leukoplakia (HP:0002745) | 3.58370880 |
| 11 | Rough bone trabeculation (HP:0100670) | 3.46974976 |
| 12 | Multiple enchondromatosis (HP:0005701) | 3.46450805 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.44532130 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.27255794 |
| 15 | Reticulocytopenia (HP:0001896) | 3.21539340 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.21497406 |
| 17 | Cholecystitis (HP:0001082) | 3.21497406 |
| 18 | Selective tooth agenesis (HP:0001592) | 3.19828535 |
| 19 | Premature ovarian failure (HP:0008209) | 3.18746760 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.15962753 |
| 21 | Ragged-red muscle fibers (HP:0003200) | 3.15597101 |
| 22 | Macrocytic anemia (HP:0001972) | 3.14105926 |
| 23 | Hepatic necrosis (HP:0002605) | 3.07998588 |
| 24 | Trismus (HP:0000211) | 3.06629338 |
| 25 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.05571554 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.05254117 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 3.04828039 |
| 28 | Abnormality of the anterior horn cell (HP:0006802) | 3.04202450 |
| 29 | Degeneration of anterior horn cells (HP:0002398) | 3.04202450 |
| 30 | Increased CSF lactate (HP:0002490) | 3.02715273 |
| 31 | Secondary amenorrhea (HP:0000869) | 2.99492752 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.97546768 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.97546768 |
| 34 | Increased serum lactate (HP:0002151) | 2.89297145 |
| 35 | Acute encephalopathy (HP:0006846) | 2.78200040 |
| 36 | Microretrognathia (HP:0000308) | 2.75900049 |
| 37 | Patellar aplasia (HP:0006443) | 2.73956179 |
| 38 | Respiratory difficulties (HP:0002880) | 2.69376292 |
| 39 | Progressive muscle weakness (HP:0003323) | 2.67675318 |
| 40 | Testicular atrophy (HP:0000029) | 2.64473641 |
| 41 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.63737428 |
| 42 | CNS demyelination (HP:0007305) | 2.63137178 |
| 43 | CNS hypomyelination (HP:0003429) | 2.61111828 |
| 44 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.60648971 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.56741714 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.56318715 |
| 47 | Leukodystrophy (HP:0002415) | 2.54378221 |
| 48 | Abnormality of the umbilical cord (HP:0010881) | 2.53925995 |
| 49 | Cerebral edema (HP:0002181) | 2.52215520 |
| 50 | Abnormal trabecular bone morphology (HP:0100671) | 2.50462292 |
| 51 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44338382 |
| 52 | Pancytopenia (HP:0001876) | 2.40974811 |
| 53 | Pallor (HP:0000980) | 2.38971275 |
| 54 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.38550726 |
| 55 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.38550726 |
| 56 | Abnormal protein glycosylation (HP:0012346) | 2.38550726 |
| 57 | Abnormal glycosylation (HP:0012345) | 2.38550726 |
| 58 | Emotional lability (HP:0000712) | 2.37931973 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.36762462 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35664064 |
| 61 | Lactic acidosis (HP:0003128) | 2.35293563 |
| 62 | Absent radius (HP:0003974) | 2.33782981 |
| 63 | Exercise intolerance (HP:0003546) | 2.33314656 |
| 64 | Hypokinesia (HP:0002375) | 2.29972253 |
| 65 | Postnatal microcephaly (HP:0005484) | 2.29690814 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.29439368 |
| 67 | Personality changes (HP:0000751) | 2.26539820 |
| 68 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.26155717 |
| 69 | Impulsivity (HP:0100710) | 2.25293077 |
| 70 | Ureteral duplication (HP:0000073) | 2.24742088 |
| 71 | Respiratory failure (HP:0002878) | 2.22436786 |
| 72 | Neoplasm of the pancreas (HP:0002894) | 2.20219715 |
| 73 | Nausea (HP:0002018) | 2.19020098 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.16683973 |
| 75 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.16647752 |
| 76 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16267540 |
| 77 | Delusions (HP:0000746) | 2.15430805 |
| 78 | Absent forearm bone (HP:0003953) | 2.15231142 |
| 79 | Aplasia involving forearm bones (HP:0009822) | 2.15231142 |
| 80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13589471 |
| 81 | Megaloblastic anemia (HP:0001889) | 2.13015499 |
| 82 | Lethargy (HP:0001254) | 2.12922855 |
| 83 | Sparse eyelashes (HP:0000653) | 2.12692613 |
| 84 | Optic disc pallor (HP:0000543) | 2.10689171 |
| 85 | Premature graying of hair (HP:0002216) | 2.09338096 |
| 86 | Entropion (HP:0000621) | 2.08437129 |
| 87 | Cellular immunodeficiency (HP:0005374) | 2.08262085 |
| 88 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07731357 |
| 89 | Horseshoe kidney (HP:0000085) | 2.05044145 |
| 90 | Colon cancer (HP:0003003) | 2.01559071 |
| 91 | Hyperglycinemia (HP:0002154) | 2.01452387 |
| 92 | Spastic paraparesis (HP:0002313) | 2.01066743 |
| 93 | Cholelithiasis (HP:0001081) | 2.00249800 |
| 94 | Death in infancy (HP:0001522) | 1.99570740 |
| 95 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.98360448 |
| 96 | Hypobetalipoproteinemia (HP:0003563) | 1.96424444 |
| 97 | Increased muscle lipid content (HP:0009058) | 1.96000471 |
| 98 | Muscle fiber splitting (HP:0003555) | 1.95861358 |
| 99 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.95435929 |
| 100 | Nemaline bodies (HP:0003798) | 1.95009337 |
| 101 | Calcaneovalgus deformity (HP:0001848) | 1.94999833 |
| 102 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.93486887 |
| 103 | Amniotic constriction ring (HP:0009775) | 1.92420158 |
| 104 | Abnormality of placental membranes (HP:0011409) | 1.92420158 |
| 105 | Poor head control (HP:0002421) | 1.91748861 |
| 106 | Absent thumb (HP:0009777) | 1.91666114 |
| 107 | Muscle fiber inclusion bodies (HP:0100299) | 1.91466062 |
| 108 | Exertional dyspnea (HP:0002875) | 1.89879923 |
| 109 | Difficulty climbing stairs (HP:0003551) | 1.89330560 |
| 110 | Aplastic anemia (HP:0001915) | 1.88799973 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.87489828 |
| 112 | Fasciculations (HP:0002380) | 1.86781395 |
| 113 | Abnormality of reticulocytes (HP:0004312) | 1.86589423 |
| 114 | Areflexia of lower limbs (HP:0002522) | 1.86262026 |
| 115 | Glossoptosis (HP:0000162) | 1.85683094 |
| 116 | Abnormality of alanine metabolism (HP:0010916) | 1.85530994 |
| 117 | Hyperalaninemia (HP:0003348) | 1.85530994 |
| 118 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85530994 |
| 119 | Unsteady gait (HP:0002317) | 1.85411983 |
| 120 | Ependymoma (HP:0002888) | 1.84875584 |
| 121 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.84485161 |
| 122 | Hyperammonemia (HP:0001987) | 1.79813225 |
| 123 | Opisthotonus (HP:0002179) | 1.79231262 |
| 124 | Meckel diverticulum (HP:0002245) | 1.78314721 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.78205783 |
| 126 | X-linked dominant inheritance (HP:0001423) | 1.76517469 |
| 127 | Cleft eyelid (HP:0000625) | 1.76052887 |
| 128 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73482216 |
| 129 | Dicarboxylic aciduria (HP:0003215) | 1.73482216 |
| 130 | Esophageal neoplasm (HP:0100751) | 1.72784880 |
| 131 | Neoplasm of head and neck (HP:0012288) | 1.72784880 |
| 132 | Broad distal phalanx of finger (HP:0009836) | 1.72103956 |
| 133 | Facial cleft (HP:0002006) | 1.71643642 |
| 134 | Abnormal gallbladder morphology (HP:0012437) | 1.70123199 |
| 135 | Abnormality of the preputium (HP:0100587) | 1.69963214 |
| 136 | Myopathic facies (HP:0002058) | 1.66162614 |
| 137 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65612761 |
| 138 | Spastic diplegia (HP:0001264) | 1.65174095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 6.11278653 |
| 2 | VRK2 | 4.65160997 |
| 3 | WEE1 | 4.31349705 |
| 4 | EIF2AK1 | 3.43954675 |
| 5 | TESK2 | 2.79402904 |
| 6 | STK16 | 2.77449014 |
| 7 | EPHA2 | 2.73367037 |
| 8 | TSSK6 | 2.57033715 |
| 9 | CDC7 | 2.51597129 |
| 10 | PLK4 | 2.31255164 |
| 11 | TTK | 2.27523181 |
| 12 | NEK1 | 2.25800572 |
| 13 | NME2 | 2.25061963 |
| 14 | SRPK1 | 2.04089189 |
| 15 | NEK2 | 1.82343015 |
| 16 | EIF2AK3 | 1.75151355 |
| 17 | PLK1 | 1.71479892 |
| 18 | PNCK | 1.64875839 |
| 19 | SMG1 | 1.63399694 |
| 20 | BCKDK | 1.62430049 |
| 21 | ACVR1B | 1.60644063 |
| 22 | NME1 | 1.60561988 |
| 23 | RPS6KB2 | 1.57770105 |
| 24 | TESK1 | 1.50982547 |
| 25 | AURKA | 1.49498083 |
| 26 | PIM2 | 1.47433897 |
| 27 | IRAK3 | 1.46443168 |
| 28 | DYRK3 | 1.44547061 |
| 29 | BRSK2 | 1.41826359 |
| 30 | MAP3K12 | 1.39978224 |
| 31 | MAP3K11 | 1.37803314 |
| 32 | AURKB | 1.36390044 |
| 33 | TLK1 | 1.35505342 |
| 34 | BRAF | 1.35495973 |
| 35 | PDK4 | 1.34986021 |
| 36 | PDK3 | 1.34986021 |
| 37 | ARAF | 1.33172167 |
| 38 | MAP3K8 | 1.28917148 |
| 39 | PLK3 | 1.26642655 |
| 40 | ZAK | 1.26027486 |
| 41 | VRK1 | 1.20839039 |
| 42 | LIMK1 | 1.19175478 |
| 43 | MAPKAPK3 | 1.12955322 |
| 44 | KDR | 1.10590519 |
| 45 | PBK | 1.08033608 |
| 46 | CDK7 | 1.07920684 |
| 47 | PAK4 | 1.07406231 |
| 48 | TRIM28 | 1.05587623 |
| 49 | CDK8 | 1.05483115 |
| 50 | DAPK1 | 1.03490548 |
| 51 | BRSK1 | 0.98181217 |
| 52 | PAK1 | 0.97081092 |
| 53 | ATR | 0.96284406 |
| 54 | PDK2 | 0.93774837 |
| 55 | CHEK2 | 0.92925044 |
| 56 | LRRK2 | 0.92609170 |
| 57 | LATS2 | 0.91001942 |
| 58 | RPS6KA4 | 0.88387641 |
| 59 | PRKCI | 0.84033831 |
| 60 | CLK1 | 0.83492916 |
| 61 | CHEK1 | 0.81520443 |
| 62 | PASK | 0.79590126 |
| 63 | SIK3 | 0.77846084 |
| 64 | CDK4 | 0.77509404 |
| 65 | STK10 | 0.77411450 |
| 66 | MKNK1 | 0.74254012 |
| 67 | ILK | 0.71880986 |
| 68 | MST4 | 0.71671487 |
| 69 | OBSCN | 0.71391094 |
| 70 | STK4 | 0.71219865 |
| 71 | CSNK2A2 | 0.70991071 |
| 72 | ABL2 | 0.68260447 |
| 73 | CSNK2A1 | 0.67638753 |
| 74 | TAF1 | 0.66746921 |
| 75 | DYRK2 | 0.66512598 |
| 76 | MST1R | 0.65072281 |
| 77 | TTN | 0.63745054 |
| 78 | SCYL2 | 0.63176622 |
| 79 | STK38L | 0.59690641 |
| 80 | EEF2K | 0.57860950 |
| 81 | TGFBR1 | 0.57626939 |
| 82 | MAP2K7 | 0.56633094 |
| 83 | CSNK1A1L | 0.56507831 |
| 84 | PIM1 | 0.54680527 |
| 85 | CDK19 | 0.51694121 |
| 86 | CCNB1 | 0.51406351 |
| 87 | CDK18 | 0.49883792 |
| 88 | CDK2 | 0.49649129 |
| 89 | BCR | 0.48652259 |
| 90 | CDK15 | 0.46300549 |
| 91 | AKT3 | 0.44677033 |
| 92 | RPS6KA5 | 0.44648590 |
| 93 | CSNK1G2 | 0.42656876 |
| 94 | TRIB3 | 0.40629716 |
| 95 | DAPK3 | 0.40610218 |
| 96 | CSNK1G3 | 0.40236394 |
| 97 | CAMK2G | 0.39372431 |
| 98 | CSNK1E | 0.39267916 |
| 99 | RAF1 | 0.39072652 |
| 100 | BLK | 0.36853313 |
| 101 | CDK1 | 0.36602725 |
| 102 | TXK | 0.35732009 |
| 103 | MAP2K2 | 0.34714954 |
| 104 | ALK | 0.34654140 |
| 105 | ATM | 0.33908607 |
| 106 | TAOK2 | 0.32643267 |
| 107 | TBK1 | 0.32602292 |
| 108 | EIF2AK2 | 0.32200759 |
| 109 | MAP4K1 | 0.31138568 |
| 110 | MELK | 0.29430508 |
| 111 | MINK1 | 0.29427880 |
| 112 | ZAP70 | 0.28061652 |
| 113 | MAPKAPK5 | 0.27466889 |
| 114 | AKT2 | 0.27085654 |
| 115 | MAPKAPK2 | 0.26789572 |
| 116 | MAP3K5 | 0.26007475 |
| 117 | MUSK | 0.25756473 |
| 118 | CSNK1G1 | 0.24271125 |
| 119 | GRK6 | 0.22744247 |
| 120 | CDK11A | 0.20512883 |
| 121 | PKN2 | 0.20443462 |
| 122 | CDK14 | 0.20348758 |
| 123 | MYLK | 0.20136642 |
| 124 | MTOR | 0.19509630 |
| 125 | MKNK2 | 0.19468258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.03450223 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.69562478 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.68091328 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.48565758 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.35911930 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.19975485 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.78747190 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.71326122 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.43262448 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.41138592 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.39384610 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.38441705 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.23856083 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.05180410 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93113750 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88790308 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.82462815 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.79999179 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72571259 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62916471 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57633286 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.55039166 |
| 23 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50258069 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45459513 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43536221 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43067756 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40824208 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37257613 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.35755401 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.26938897 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.26689064 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25191684 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21106191 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20360401 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13492982 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12452310 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10790063 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10499220 |
| 39 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05838178 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.05326343 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03260460 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97382110 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96725937 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.95562268 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91820330 |
| 46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.91162006 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91024573 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89785325 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88871118 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.85867943 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84611771 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84386956 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84337122 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83807989 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81545369 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77124633 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76288691 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70383260 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67543818 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64516724 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.63923701 |
| 62 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63851331 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61644605 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60007546 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57560387 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55798784 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55385081 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54171751 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53281113 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48257835 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47417848 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46851145 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43775535 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42847498 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41561182 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40813478 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39184357 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34950222 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31967913 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28916944 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28841848 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.28302790 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.26882577 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26799575 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25544056 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23988092 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23663828 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.22941533 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22926927 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22721650 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22677969 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22517326 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22113415 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.21530441 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19888164 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17918674 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16924253 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.16839352 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16655382 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16375443 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.16304171 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15271308 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.14942994 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14804881 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13384686 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.12864349 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.12621032 |
| 108 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11062805 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10689669 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10578725 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10468937 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09869425 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.06718100 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.06625544 |

